Literature DB >> 7691785

Measurable impact: multimodality therapy of head and neck cancer.

E E Vokes, R R Weichselbaum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7691785     DOI： 10.1016/0360-3016(93)90263-u

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  8 in total

1.  Weekly cisplatin concurrently with radiotherapy in head and neck squamous cell cancer: a retrospective analysis of a tertiary institute experience.

Authors:  Nemer Osman; Yasir Y Elamin; Shereen Rafee; Cathal O'Brien; Leo F A Stassen; Conrad Timon; John Kinsella; Sinead Brennan; Kenneth J O'Byrne
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08       Impact factor: 2.503

Review 2.  [Radiobiological mechanisms for new strategies in radiochemotherapy].

Authors:  K R Trott
Journal:  Strahlenther Onkol       Date:  1998-08       Impact factor: 3.621

3.  Impact of radiotherapy on microsurgical reconstruction of the head and neck.

Authors:  Bettina Hohlweg-Majert; Oliver Ristow; Katharina Gust; Victoria Kehl; Klaus-Dietrich Wolff; Steffi Pigorsch
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-20       Impact factor: 4.553

4.  Chemoradiation in Advanced Head and Neck Cancers: A Comparison of two Radiosensitizers, Paclitaxel and Cisplatin.

Authors:  Sohit Paul Kanotra; Sonika Kanotra; Ashutosh Gupta; J Paul
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-05-07

5.  [Constitutive expression of the potential stem cell marker CD44 in permanent HNSCC cell lines].

Authors:  R Pries; N Wittkopf; K Hasselbacher; B Wollenberg
Journal:  HNO       Date:  2008-04       Impact factor: 1.284

Review 6.  ENT COBRA (Consortium for Brachytherapy Data Analysis): interdisciplinary standardized data collection system for head and neck patients treated with interventional radiotherapy (brachytherapy).

Authors:  Luca Tagliaferri; György Kovács; Rosa Autorino; Ashwini Budrukkar; Jose Luis Guinot; Guido Hildebrand; Bengt Johansson; Rafael Martìnez Monge; Jens E Meyer; Peter Niehoff; Angeles Rovirosa; Zoltàn Takàcsi-Nagy; Nicola Dinapoli; Vito Lanzotti; Andrea Damiani; Tamer Soror; Vincenzo Valentini
Journal:  J Contemp Brachytherapy       Date:  2016-08-26

7.  Cessation Attitudes and Preferences in Head and Neck Cancer Patients and Implications for Cessation Program Design: A Brief Report.

Authors:  Chandylen L Nightingale; Katherine R Sterba; Janet A Tooze; Jessica L King; Kathryn E Weaver
Journal:  Glob Adv Health Med       Date:  2019-04-30

8.  Targeting serum glucocorticoid-regulated kinase-1 in squamous cell carcinoma of the head and neck: a novel modality of local control.

Authors:  Henrik O Berdel; Hongyu Yin; Jun Yao Liu; Karolina Grochowska; Christopher Middleton; Nathan Yanasak; Rafik Abdelsayed; Wolfgang E Berdel; Mahmood Mozaffari; Jack C Yu; Babak Baban
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.